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ncreasing Post-Myocardial
nfarction Heart Failure
ncidence in Elderly Patients
Call for Action*
hang-seng Liang, MD, PHD, FACC,
oseph D. Delehanty, MD, FACC
ochester, New York
he impact of heart failure on the global health care
ommunity has long been recognized. Ischemic heart dis-
ase is a major cause of heart failure. In the last 30 years
here have been dramatic advances in the management of
schemic heart disease in general and acute myocardial
nfarction (MI) specifically. Although the risk of dying of
cute MI and coronary artery disease has declined, the
ortality rate from congestive heart failure (CHF) has
eclined to a much lesser extent (1,2). The number of
ospitalizations with CHF as either the principal or the
econdary diagnosis in patients over the age of 65 years has
ctually increased by 70% to 100% over the last 25 years (3).
See page 13
ne possible explanation for this increase is that the
atients who are now surviving the acute MI are subse-
uently succumbing to the consequences of the MI. The
tudy by Ezekowitz et al. (4) in this issue of the Journal
akes an attempt to investigate this further. The investiga-
ors followed up a cohort of patients over the age of 65 years
ho presented with a first MI over a 6-year period in
lberta, Canada. They determined the outcomes of the
cute hospitalization in terms of whether the patients
urvived the hospitalization and whether they had the
iagnosis of CHF. In addition to events during the initial
ospitalization, the investigators followed up the patients
ver a period of 5 years to determine whether they died and
lso whether CHF developed. The data were obtained from
dministrative databases and were quite complete in terms
f determining the vital status of the patients, but were
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.i
From the Division of Cardiology, Department of Medicine, University of Rochester
edical Center, Rochester, New York.dmittedly less complete in terms of the cause of death and
ther important cardiovascular variables such as left ventric-
lar (LV) ejection fraction, presence or absence of ventric-
lar tachyarrhythmia, or whether the index event was a
T-segment elevation or non–ST-segment elevation MI.
he diagnosis of CHF during the index admission or
ubsequently was made by using insurance claims using the
nternational Classification of Diseases-9th Revision codes
or CHF. Although this method of diagnosing a complex
ondition such as CHF could certainly be questioned, there
re data to suggest that it does correlate well with chart
eview methods (5), although if there is an error, it is likely
hat the diagnosis of CHF was under-reported (6). Even
ith these significant limitations, the investigators are to be
ongratulated in collecting and analyzing data on such a
arge number of consecutive patients treated in a real-world
ractice. The most important finding of this analysis was
hat during the study period from 1994 to 2000, there was
significant decrease in the mortality rate from the first MI,
ut at the same time there was an increase in the rate of
HF developing from that hospitalization on. Perhaps the
ost surprising finding of the investigation was that the
ercentage of patients in whom CHF developed within 5
ears of the index event was 76% and that the 5-year
ortality rate in these patients with CHF was 39.1%,
hich is much higher than the 26.7% mortality rate in
hose patients in whom CHF did not develop. Given this
ery high incidence of CHF in the population, it is
ppropriate for clinicians to ask what if anything can be
one to reduce it.
Because it is an observational study, the investigators
annot really explain the basis of the findings and the reader
ust take care in interpreting such findings as establishing
echanisms of disease. Such a study does, however, raise
any questions and hypotheses that should be examined
urther. The 2 interventions that were associated with a
ecrease in mortality caused by acute MI were the use of
ppropriate medical therapy such as beta-blockers,
ngiotensin-converting enzyme (ACE) inhibitors, and
tatins, and also early coronary revascularization. It is a
easonable hypothesis that interventions that limit infarct
ize such as timely reperfusion therapy would likely reduce
he development of CHF. In this cohort of patients, only a
inority of the patients underwent invasive revasculariza-
ion during the index MI. It is certainly possible that if there
ere greater utilization of rapid reperfusion in these pa-
ients, there would be a lower incidence of subsequent heart
ailure. This speculation is supported by data from the same
nvestigators that in an unselected population with MI, the
se of invasive coronary revascularization was associated
ith a reduction in the risk of subsequent development of
eart failure and that this finding persisted after adjustment
or other risk factors for heart failure including advanced age
7). It is likely, however, that many of these patients did not
n fact have significantly reduced LV systolic function,
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reserved systolic function in this elderly population (8,9).
n this case, coronary reperfusion may not result in dramatic
ecreases in the incidence of heart failure. Lack of LV
ystolic function measurements hampers interpretation of
he data in the study by Ezekowitz et al. (4). A randomized
rial would be needed to answer this question directly.
The use of statins and beta-blockers were associated with
reduced incidence of heart failure as well as a reduced
ortality. This is certainly consistent with what we know
bout the effects of beta-blockers in patients with estab-
ished CHF as well as asymptomatic LV dysfunction. The
ffect of statins, however, is not as well established. The
ffectiveness of statins in elderly patients with CHF is not
lear, with recent studies suggesting a lack of effect (10).
he lack of effect of ACE inhibitors on the development of
HF is somewhat perplexing, especially if one postulates
hat LV dysfunction is the primary cause of CHF. This also
aises the question of whether much of the CHF that
ccurred in this patient population did so in the presence of
elatively well-preserved systolic function, in which case the
enefit of ACE inhibitors is less well established (11,12).
An issue that is not addressed in this study is that of the
se of automated implantable cardioverter-defibrillators
AICDs) in this high-risk population. In the absence of data
n ventricular function, one cannot be certain of what
ercentage of patients may have qualified for defibrillators,
nd the study did not include AICD usage. Having said
hat, aggressive use of defibrillators probably would not have
hanged the conclusions significantly. It is unfortunate that
he databases in Alberta, Canada, did not allow the inves-
igators to determine the modes of death. Thus, it is not
ossible to know the percentage of patients who died
uddenly, presumably from arrhythmic death, versus those
rom progressive heart failure or from re-infarction/
schemia. National databases probably should be amended
o include more pertinent data so that the clinical outcomes
ould be analyzed more intelligently.
So what can the practicing physician take away from this
tudy? Certainly it is clear that an MI is very significant
vent in this population, not only in terms of short-term
ortality, but also a marker of poor long-term prognosis. In
his population, even what would otherwise be considered as
low-risk MI should be viewed, in the terms of the authors,
s a “sentinel event,” prompting early recognition of the risk
nd hopefully strategies to reduce that risk. We can feel
elatively confident that adherence to evidence-based prac-
ice will improve short-term prognosis and will likely
mprove longer-term prognosis. There does seem to be a
ifference in the use of evidence-based strategies in the
lderly population compared with the younger population
13). This study by Ezekowitz et al. (4) does suggest that
loser adherence to evidence-based strategies in this popu-
ation may improve the long-term outcome after first MI.
ore work will need to be done to determine that mecha-
ism behind the high incidence of heart failure in thisopulation, and once that has been more clearly ascertained,
trategies to alter the risk can be rationally designed.
An area that will need to be examined in this elderly
opulation in particular is cost. This is likely to be rather
ontentious, but given the numbers of patients that are
eing considered, one could certainly question the frequent
se of high-cost interventions such as defibrillators and
nvasive revascularization in this population. Although el-
erly was defined as older than 65 years for the purpose of
his study, we are more frequently seeing patients presenting
n the 8th and 9th decades of life, and such patients may
ell need to be considered differently from the younger
lderly patients. Data on the response of such very elderly
atients to these types of interventions are sorely lacking.
hat little data there are seem to suggest that it is in such
atients at high risk that the benefit may be greatest (13). In
he absence of clear-cut data supporting one strategy, and
ecause the data are unlikely to be forthcoming soon,
linicians will need to continue doing what we should have
one until now: make decisions based on individual patient
resentations, presenting all information to the patient
ncluding what we think the risks are of intervening or not
ntervening, and then making the decision with the active
articipation of the patient (14). It is probably not good
ractice to set arbitrary age limits on the appropriateness of
he various interventions; however, given the rapidly ad-
ancing age of our general population and the precarious-
ess of the national economic situation, such discussions are
ikely to occur, and it will be incumbent on us as physicians
o have as much information as possible; careful analysis of
ata such as was done in this study is a good beginning.
eprint requests and correspondence: Dr. Chang-seng Liang,
oston Medical Center, Cardiovascular Medicine, 88 East Newton
treet, Boston, Massachusetts 02118. E-mail: chang-seng.liang@
mc.org.
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